{"id":46058,"date":"2025-10-14T12:52:04","date_gmt":"2025-10-14T10:52:04","guid":{"rendered":"https:\/\/digidem-bayern.de\/?p=46058"},"modified":"2025-11-04T09:35:03","modified_gmt":"2025-11-04T08:35:03","slug":"webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick","status":"publish","type":"post","link":"https:\/\/digidem-bayern.de\/en\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/","title":{"rendered":"Webinar: Entwicklung neuer Medikamente gegen Demenzen \u2013 Stand und Ausblick"},"content":{"rendered":"

Nach Jahrzehnten der stagnierenden Forschung gibt es wieder Bewegung: Neue monoklonale Antik\u00f6rper gegen Amyloid-Ablagerungen wie Lecanemab oder Donanemab greifen erstmals direkt in die Krankheitsmechanismen der Alzheimer Demenz ein. Bisherige Medikamente konnten lediglich die Symptome lindern, aber nicht das Fortschreiten der Krankheit verlangsamen. Wie vielversprechend sind die neuen Medikamente \u2013 und was ist in den kommenden Jahren an weiteren Neurungen zu erwarten? Und wie wird die Sicherheit und die Wirksamkeit neuer Medikamente in klinischen Studien eigentlich gemessen? <\/p>\n\n\n\n

Im kommenden Webinar gibt Prof. Dr. Peter Sch\u00fcler<\/strong> einen \u00dcberblick \u00fcber den aktuellen Stand der Entwicklung von Medikamenten gegen Demenz. Dabei wird er sowohl \u00fcber laufende Studien als auch zuk\u00fcnftige M\u00f6glichkeiten und Herausforderungen im Bereich der Arzneimittelentwicklung sprechen. Prof. Dr. Peter Sch\u00fcler ist Senior Vice President im Bereich „Drug Development Solutions, Neurosciences“ bei der globalen\u00a0ICON Clinical Research Germany GmbH<\/em>\u00a0mit Sitz in Langen (Hessen).\u00a0<\/em>Dar\u00fcber hinaus war er Vorsitzender der Deutschen Gesellschaft f\u00fcr Pharmazeutische Medizin e.V. 2023-2025 und ist Mitglied im digiDEM Bayern Scientific Advisory Board.<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

Dienstag, 28.10.2025, 11:00 – 11:45 Uhr<\/strong><\/strong><\/h2>\n\n\n\n
\u00a0Melden Sie sich hier an<\/a><\/div><\/div><\/div>\n\n\n\n
\n
\n
\"Florian

Florian Weidinger<\/h3>Wissenschaftlicher Mitarbeiter M.Sc. <\/span>

Moderation<\/p><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n\n

\n
\"\"

Anne Keefer<\/h3>Wissenschaftliche Mitarbeiterin M.Sc.<\/span>

Chatroom und Betreuung<\/p><\/div><\/div>\n<\/div><\/div><\/div>\n<\/div><\/div>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"

Nach Jahrzehnten der stagnierenden Forschung gibt es wieder Bewegung: Neue monoklonale Antik\u00f6rper gegen Amyloid-Ablagerungen wie Lecanemab oder Donanemab greifen erstmals direkt in die Krankheitsmechanismen der Alzheimer Demenz ein. Bisherige Medikamente konnten lediglich die Symptome lindern, aber nicht das Fortschreiten der Krankheit verlangsamen. Wie vielversprechend sind die neuen Medikamente \u2013 und …<\/p>","protected":false},"author":12,"featured_media":46060,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"qubely_global_settings":"true","qubely_interactions":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[8,350],"tags":[13,1682,12,177,165,14,17,55,1683,420,1680,1684,890,940,892,566,1679,1678,80,1681,891],"class_list":["post-46058","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aktuelles-zu-digidem","category-kommendes-webinar","tag-alzheimer","tag-bern","tag-demenz-2","tag-demenzrisiko","tag-deutsche-alzheimer-gesellschaft","tag-digidem","tag-digidem-bayern","tag-digitales-demenzregister-bayern","tag-frauenheilkunde","tag-gedaechtnisleistung","tag-hitzewallungen","tag-hormone","tag-hormonersatztherapie","tag-kognitive-gesundheit","tag-menopause","tag-menschen-mit-demenz","tag-petra-stute","tag-prof-dr-med-petra-stute","tag-schlafstoerungen","tag-stimmungsschwankung","tag-wechseljahre"],"qubely_featured_image_url":{"full":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"portraits":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-540x320.jpg",540,320,true],"thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-80x80.jpg",80,80,true],"medium":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-300x200.jpg",300,200,true],"medium_large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-768x511.jpg",768,511,true],"large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"1536x1536":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"2048x2048":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"trp-custom-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",18,12,false],"qubely_landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"qubely_portrait":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-540x320.jpg",540,320,true],"qubely_thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-140x100.jpg",140,100,true],"post-thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-526x350.jpg",526,350,true],"kahuna-featured":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-734x350.jpg",734,350,true],"kahuna-featured-lp":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-520x350.jpg",520,350,true],"kahuna-featured-half":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-800x350.jpg",800,350,true],"kahuna-featured-third":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-512x350.jpg",512,350,true],"kahuna-lpbox-1":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-520x300.jpg",520,300,true],"kahuna-lpbox-2":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-520x350.jpg",520,350,true],"demand-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-36x36.jpg",36,36,true],"dddkt-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-36x36.jpg",36,36,true],"ddiqc-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-36x36.jpg",36,36,true],"ddtl-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-36x36.jpg",36,36,true],"mailpoet_newsletter_max":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"kahuna-lpbox-3":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-520x350.jpg",520,350,true],"kahuna-featured-square":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-512x512.jpg",512,512,true],"kahuna-featured-square-large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false]},"qubely_author":{"display_name":"Ilona H\u00f6rath","author_link":"https:\/\/digidem-bayern.de\/en\/author\/hoeratia\/"},"qubely_comment":10,"qubely_category":"Aktuelles zu digiDEM<\/a> Kommendes Webinar<\/a>","qubely_excerpt":"Nach Jahrzehnten der stagnierenden Forschung gibt es wieder Bewegung: Neue monoklonale Antik\u00f6rper gegen Amyloid-Ablagerungen wie Lecanemab oder Donanemab greifen erstmals direkt in die Krankheitsmechanismen der Alzheimer Demenz ein. Bisherige Medikamente konnten lediglich die Symptome lindern, aber nicht das Fortschreiten der Krankheit verlangsamen. Wie vielversprechend sind die neuen Medikamente \u2013 und …","featured_image_urls_v2":{"full":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-80x80.jpg",80,80,true],"medium":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-300x200.jpg",300,200,true],"medium_large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-768x511.jpg",768,511,true],"large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"1536x1536":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"2048x2048":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"trp-custom-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",18,12,false],"qubely_landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"qubely_portrait":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-540x320.jpg",540,320,true],"qubely_thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-140x100.jpg",140,100,true],"post-thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-526x350.jpg",526,350,true],"kahuna-featured":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-734x350.jpg",734,350,true],"kahuna-featured-lp":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-520x350.jpg",520,350,true],"kahuna-featured-half":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-800x350.jpg",800,350,true],"kahuna-featured-third":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-512x350.jpg",512,350,true],"kahuna-lpbox-1":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-520x300.jpg",520,300,true],"kahuna-lpbox-2":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-520x350.jpg",520,350,true],"demand-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-36x36.jpg",36,36,true],"dddkt-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-36x36.jpg",36,36,true],"ddiqc-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-36x36.jpg",36,36,true],"ddtl-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-36x36.jpg",36,36,true],"mailpoet_newsletter_max":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"kahuna-lpbox-3":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-520x350.jpg",520,350,true],"kahuna-featured-square":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-512x512.jpg",512,512,true],"kahuna-featured-square-large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false]},"post_excerpt_stackable_v2":"

Nach Jahrzehnten der stagnierenden Forschung gibt es wieder Bewegung: Neue monoklonale Antik\u00f6rper gegen Amyloid-Ablagerungen wie Lecanemab oder Donanemab greifen erstmals direkt in die Krankheitsmechanismen der Alzheimer Demenz ein. Bisherige Medikamente konnten lediglich die Symptome lindern, aber nicht das Fortschreiten der Krankheit verlangsamen. Wie vielversprechend sind die neuen Medikamente \u2013 und was ist in den kommenden Jahren an weiteren Neurungen zu erwarten? Und wie wird die Sicherheit und die Wirksamkeit neuer Medikamente in klinischen Studien eigentlich gemessen? Im kommenden Webinar gibt Prof. Dr. Peter Sch\u00fcler einen \u00dcberblick \u00fcber den aktuellen Stand der Entwicklung von Medikamenten gegen Demenz. Dabei wird er sowohl…<\/p>\n","category_list_v2":"Aktuelles zu digiDEM<\/a>, Kommendes Webinar<\/a>","author_info_v2":{"name":"Ilona H\u00f6rath","url":"https:\/\/digidem-bayern.de\/en\/author\/hoeratia\/"},"comments_num_v2":"0 comments","yoast_head":"\nWebinar: Entwicklung neuer Medikamente gegen Demenzen \u2013 Stand und Ausblick - digiDEM Bayern<\/title>\n<meta name=\"description\" content=\"Im Webinar "digiDEM Bayern Science Watch LIVE" behandeln Wissenschaftler ein Thema aus der Demenzforschung und stehen live f\u00fcr Fragen zur Verf\u00fcgung.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/digidem-bayern.de\/en\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Webinar: Entwicklung neuer Medikamente gegen Demenzen \u2013 Stand und Ausblick - digiDEM Bayern\" \/>\n<meta property=\"og:description\" content=\"Im Webinar "digiDEM Bayern Science Watch LIVE" behandeln Wissenschaftler ein Thema aus der Demenzforschung und stehen live f\u00fcr Fragen zur Verf\u00fcgung.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/digidem-bayern.de\/en\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/\" \/>\n<meta property=\"og:site_name\" content=\"digiDEM Bayern\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/digiDEMBayern\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-14T10:52:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-04T08:35:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"666\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ilona H\u00f6rath\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ilona H\u00f6rath\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/\"},\"author\":{\"name\":\"Ilona H\u00f6rath\",\"@id\":\"\\\/#\\\/schema\\\/person\\\/0bc1494f46fc2a051c761322a80e0941\"},\"headline\":\"Webinar: Entwicklung neuer Medikamente gegen Demenzen \u2013 Stand und Ausblick\",\"datePublished\":\"2025-10-14T10:52:04+00:00\",\"dateModified\":\"2025-11-04T08:35:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/\"},\"wordCount\":203,\"commentCount\":0,\"publisher\":{\"@id\":\"\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/shutterstock_2499290699-webinar-Schueler.jpg\",\"keywords\":[\"Alzheimer\",\"Bern\",\"Demenz\",\"Demenzrisiko\",\"Deutsche Alzheimer Gesellschaft\",\"digidem\",\"digidem Bayern\",\"Digitales Demenzregister Bayern\",\"Frauenheilkunde\",\"Ged\u00e4chtnisleistung\",\"Hitzewallungen\",\"Hormone\",\"Hormonersatztherapie\",\"kognitive Gesundheit\",\"Menopause\",\"Menschen mit Demenz\",\"Petra Stute\",\"Prof. Dr. med. Petra Stute\",\"Schlafst\u00f6rungen\",\"Stimmungsschwankung\",\"Wechseljahre\"],\"articleSection\":[\"Aktuelles zu digiDEM\",\"Kommendes Webinar\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/\",\"name\":\"Webinar: Entwicklung neuer Medikamente gegen Demenzen \u2013 Stand und Ausblick - digiDEM Bayern\",\"isPartOf\":{\"@id\":\"\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/shutterstock_2499290699-webinar-Schueler.jpg\",\"datePublished\":\"2025-10-14T10:52:04+00:00\",\"dateModified\":\"2025-11-04T08:35:03+00:00\",\"description\":\"Im Webinar \\\"digiDEM Bayern Science Watch LIVE\\\" behandeln Wissenschaftler ein Thema aus der Demenzforschung und stehen live f\u00fcr Fragen zur Verf\u00fcgung.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/#primaryimage\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/shutterstock_2499290699-webinar-Schueler.jpg\",\"contentUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/shutterstock_2499290699-webinar-Schueler.jpg\",\"width\":1000,\"height\":666,\"caption\":\"Wie vielversprechend sind die neuen Medikamente \u2013 und was ist in den kommenden Jahren an weiteren Neurungen zu erwarten?\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/digidem-bayern.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Webinar: Entwicklung neuer Medikamente gegen Demenzen \u2013 Stand und Ausblick\"}]},{\"@type\":\"WebSite\",\"@id\":\"\\\/#website\",\"url\":\"\\\/\",\"name\":\"digiDEM Bayern\",\"description\":\"Das digitale Demenzregister Bayern erforscht und verbessert die Angebotsstuktur f\u00fcr Menschen mit Demenz und deren Angeh\u00f6rige\",\"publisher\":{\"@id\":\"\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"\\\/#organization\",\"name\":\"digiDEM Bayern\",\"url\":\"\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png\",\"contentUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png\",\"width\":612,\"height\":357,\"caption\":\"digiDEM Bayern\"},\"image\":{\"@id\":\"\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/digiDEMBayern\\\/\",\"https:\\\/\\\/x.com\\\/digidem_bayern\",\"https:\\\/\\\/www.instagram.com\\\/digidem.bayern\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/digidem-bayern\\\/\"]},{\"@type\":\"Person\",\"@id\":\"\\\/#\\\/schema\\\/person\\\/0bc1494f46fc2a051c761322a80e0941\",\"name\":\"Ilona H\u00f6rath\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/en\\\/author\\\/hoeratia\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Webinar: Entwicklung neuer Medikamente gegen Demenzen \u2013 Stand und Ausblick - digiDEM Bayern","description":"Im Webinar \"digiDEM Bayern Science Watch LIVE\" behandeln Wissenschaftler ein Thema aus der Demenzforschung und stehen live f\u00fcr Fragen zur Verf\u00fcgung.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/digidem-bayern.de\/en\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/","og_locale":"en_US","og_type":"article","og_title":"Webinar: Entwicklung neuer Medikamente gegen Demenzen \u2013 Stand und Ausblick - digiDEM Bayern","og_description":"Im Webinar \"digiDEM Bayern Science Watch LIVE\" behandeln Wissenschaftler ein Thema aus der Demenzforschung und stehen live f\u00fcr Fragen zur Verf\u00fcgung.","og_url":"https:\/\/digidem-bayern.de\/en\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/","og_site_name":"digiDEM Bayern","article_publisher":"https:\/\/www.facebook.com\/digiDEMBayern\/","article_published_time":"2025-10-14T10:52:04+00:00","article_modified_time":"2025-11-04T08:35:03+00:00","og_image":[{"width":1000,"height":666,"url":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg","type":"image\/jpeg"}],"author":"Ilona H\u00f6rath","twitter_misc":{"Written by":"Ilona H\u00f6rath","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/#article","isPartOf":{"@id":"https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/"},"author":{"name":"Ilona H\u00f6rath","@id":"\/#\/schema\/person\/0bc1494f46fc2a051c761322a80e0941"},"headline":"Webinar: Entwicklung neuer Medikamente gegen Demenzen \u2013 Stand und Ausblick","datePublished":"2025-10-14T10:52:04+00:00","dateModified":"2025-11-04T08:35:03+00:00","mainEntityOfPage":{"@id":"https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/"},"wordCount":203,"commentCount":0,"publisher":{"@id":"\/#organization"},"image":{"@id":"https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/#primaryimage"},"thumbnailUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg","keywords":["Alzheimer","Bern","Demenz","Demenzrisiko","Deutsche Alzheimer Gesellschaft","digidem","digidem Bayern","Digitales Demenzregister Bayern","Frauenheilkunde","Ged\u00e4chtnisleistung","Hitzewallungen","Hormone","Hormonersatztherapie","kognitive Gesundheit","Menopause","Menschen mit Demenz","Petra Stute","Prof. Dr. med. Petra Stute","Schlafst\u00f6rungen","Stimmungsschwankung","Wechseljahre"],"articleSection":["Aktuelles zu digiDEM","Kommendes Webinar"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/","url":"https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/","name":"Webinar: Entwicklung neuer Medikamente gegen Demenzen \u2013 Stand und Ausblick - digiDEM Bayern","isPartOf":{"@id":"\/#website"},"primaryImageOfPage":{"@id":"https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/#primaryimage"},"image":{"@id":"https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/#primaryimage"},"thumbnailUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg","datePublished":"2025-10-14T10:52:04+00:00","dateModified":"2025-11-04T08:35:03+00:00","description":"Im Webinar \"digiDEM Bayern Science Watch LIVE\" behandeln Wissenschaftler ein Thema aus der Demenzforschung und stehen live f\u00fcr Fragen zur Verf\u00fcgung.","breadcrumb":{"@id":"https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/#primaryimage","url":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg","contentUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg","width":1000,"height":666,"caption":"Wie vielversprechend sind die neuen Medikamente \u2013 und was ist in den kommenden Jahren an weiteren Neurungen zu erwarten?"},{"@type":"BreadcrumbList","@id":"https:\/\/digidem-bayern.de\/webinar-entwicklung-neuer-medikamente-gegen-demenzen-stand-und-ausblick\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/digidem-bayern.de\/"},{"@type":"ListItem","position":2,"name":"Webinar: Entwicklung neuer Medikamente gegen Demenzen \u2013 Stand und Ausblick"}]},{"@type":"WebSite","@id":"\/#website","url":"\/","name":"digiDEM Bavaria","description":"The digital dementia register in Bavaria researches and improves the structure of services for people with dementia and their relatives","publisher":{"@id":"\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"\/#organization","name":"digiDEM Bavaria","url":"\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"\/#\/schema\/logo\/image\/","url":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2022\/03\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png","contentUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2022\/03\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png","width":612,"height":357,"caption":"digiDEM Bayern"},"image":{"@id":"\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/digiDEMBayern\/","https:\/\/x.com\/digidem_bayern","https:\/\/www.instagram.com\/digidem.bayern","https:\/\/www.linkedin.com\/company\/digidem-bayern\/"]},{"@type":"Person","@id":"\/#\/schema\/person\/0bc1494f46fc2a051c761322a80e0941","name":"Ilona H\u00f6rath","url":"https:\/\/digidem-bayern.de\/en\/author\/hoeratia\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-80x80.jpg",80,80,true],"medium":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-300x200.jpg",300,200,true],"medium_large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-768x511.jpg",768,511,true],"large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"1536x1536":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"2048x2048":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"trp-custom-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",18,12,false],"qubely_landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"qubely_portrait":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-540x320.jpg",540,320,true],"qubely_thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-140x100.jpg",140,100,true],"post-thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-526x350.jpg",526,350,true],"kahuna-featured":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-734x350.jpg",734,350,true],"kahuna-featured-lp":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-520x350.jpg",520,350,true],"kahuna-featured-half":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-800x350.jpg",800,350,true],"kahuna-featured-third":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-512x350.jpg",512,350,true],"kahuna-lpbox-1":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-520x300.jpg",520,300,true],"kahuna-lpbox-2":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-520x350.jpg",520,350,true],"demand-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-36x36.jpg",36,36,true],"dddkt-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-36x36.jpg",36,36,true],"ddiqc-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-36x36.jpg",36,36,true],"ddtl-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-36x36.jpg",36,36,true],"mailpoet_newsletter_max":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false],"kahuna-lpbox-3":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-520x350.jpg",520,350,true],"kahuna-featured-square":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler-512x512.jpg",512,512,true],"kahuna-featured-square-large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2025\/10\/shutterstock_2499290699-webinar-Schueler.jpg",1000,666,false]},"uagb_author_info":{"display_name":"Ilona H\u00f6rath","author_link":"https:\/\/digidem-bayern.de\/en\/author\/hoeratia\/"},"uagb_comment_info":10,"uagb_excerpt":"Nach Jahrzehnten der stagnierenden Forschung gibt es wieder Bewegung: Neue monoklonale Antik\u00f6rper gegen Amyloid-Ablagerungen wie Lecanemab oder Donanemab greifen erstmals direkt in die Krankheitsmechanismen der Alzheimer Demenz ein. Bisherige Medikamente konnten lediglich die Symptome lindern, aber nicht das Fortschreiten der Krankheit verlangsamen. Wie vielversprechend sind die neuen Medikamente \u2013 und …","_links":{"self":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts\/46058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/comments?post=46058"}],"version-history":[{"count":3,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts\/46058\/revisions"}],"predecessor-version":[{"id":46218,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts\/46058\/revisions\/46218"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/media\/46060"}],"wp:attachment":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/media?parent=46058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/categories?post=46058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/tags?post=46058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}